# ACT-GLOBAL Adaptive Platform Trial for Stroke

Study · id `cardio:ct-nct06352632` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06352632](<https://clinicaltrials.gov/study/NCT06352632>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT06352632

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 20000 participants.

## Technical summary

Registry record NCT06352632. Randomized; single masking; primary purpose treatment. Start 2024-09-26 (actual); primary completion 2034-09 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 20000 participants (planned count; ClinicalTrials.gov record NCT06352632, source copy `cardio:ctgov-nct06352632-2026-11-10`, retrieved 2026-11-18)
- Started: 2024-09-26 (actual) (ClinicalTrials.gov record NCT06352632, source copy `cardio:ctgov-nct06352632-2026-11-10`, retrieved 2026-11-18)
- Primary completion: 2034-09 (anticipated) (ClinicalTrials.gov record NCT06352632, source copy `cardio:ctgov-nct06352632-2026-11-10`, retrieved 2026-11-18)
- Completion: 2034-09 (anticipated) (ClinicalTrials.gov record NCT06352632, source copy `cardio:ctgov-nct06352632-2026-11-10`, retrieved 2026-11-18)
- Countries: Australia; Canada (ClinicalTrials.gov record NCT06352632, source copy `cardio:ctgov-nct06352632-2026-11-10`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06352632-2026-11-10`, retrieved 2026-11-18)

## The registry's words

- Brief title: ACT-GLOBAL Adaptive Platform Trial for Stroke
- Condition: Stroke
- Intervention (Drug): Standard-dose intravenous tenecteplase
- Intervention (Drug): Low-dose intravenous tenecteplase
- Intervention (Other): No intravenous tenecteplase
- Intervention (Other): Conservative Blood Pressure Control
- Intervention (Other): Moderate Blood Pressure Control
- Intervention (Other): Intensive Blood Pressure Control
- Intervention (Other): Placebo
- Intervention (Drug): NoNO-42
- Intervention (Other): No deferoxamine mesylate and no colchicine
- Intervention (Drug): Deferoxamine mesylate only
- Intervention (Drug): Colchicine only
- Intervention (Drug): Both deferoxamine mesylate and colchicine
- Intervention (Drug): IA thrombolysis
- Intervention (Other): no IA thrombolysis
- Intervention (Other): IMP-ACT usual care
- Intervention (Procedure): IMP-ACT mechanical endovascular thrombectomy
- Intervention (Drug): Intra-arterial tenecteplase or alteplase in IMP-ACT
- Intervention (Drug): CoPRIME aspirin alone
- Intervention (Drug): CoPRIME aspirin plus clopidogrel
- Intervention (Drug): CoPRIME aspirin plus ticagrelor
- Lead sponsor: The George Institute
- Lead sponsor class: OTHER
- Collaborator: University of Calgary
- Collaborator class: OTHER
- Collaborator: Berry Consultants
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Bleeding in the brain (intracerebral hemorrhage) (`cardio:intracerebral-hemorrhage`)
- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: The George Institute for Global Health (`core:george-institute`)
- Registry lists this organization as a collaborator: University of Calgary (`cardio:org-university-of-calgary`)
- Registry lists this organization as a collaborator: Berry Consultants (`cardio:org-berry-consultants`)

## Provenance

Content hash: 3ff170ff0ce7510bcdf6ac8f49c4ea396ee74df9e54de27f1c6b00f7f0814267
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
